Stock FIGS FIGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials FIGS, Inc.

Equities

FIGS

US30260D1037

Medical Equipment, Supplies & Distribution

Market Closed - Nyse
Other stock markets
 21:00:02 26/04/2024 BST 		5-day change 1st Jan Change
4.92 USD +2.29% Intraday chart for FIGS, Inc. +2.71% -29.21%
04-23 Goldman Sachs Adjusts Price Target on FIGS to $4.25 From $4.85, Maintains Sell Rating MT
04-03 North American Morning Briefing : Powell Awaited -2- DJ

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Capitalization 1 4,505 1,117 1,175 837.1 - -
Enterprise Value (EV) 1 4,310 957.2 1,175 580.8 520.1 467.2
P/E ratio -459 x 61.2 x 57.9 x 89.5 x 36.7 x 30.8 x
Yield - - - - - -
Capitalization / Revenue 10.7 x 2.21 x 2.15 x 1.58 x 1.51 x 1.43 x
EV / Revenue 10.3 x 1.89 x 2.15 x 1.09 x 0.94 x 0.8 x
EV / EBITDA 40.9 x 11 x 13.7 x 9.59 x 6.75 x 5.77 x
EV / FCF 67.6 x -23.5 x - 14.6 x 10.2 x 11.6 x
FCF Yield 1.48% -4.25% - 6.85% 9.85% 8.62%
Price to Book 17.9 x 4.1 x - 1.95 x 1.74 x 1.55 x
Nbr of stocks (in thousands) 163,457 165,963 169,135 170,148 - -
Reference price 2 27.56 6.730 6.950 4.920 4.920 4.920
Announcement Date 08/03/22 28/02/23 28/02/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Net sales 1 419.6 505.8 545.6 531.2 555.6 583.5
EBITDA 1 105.2 87.25 86 60.56 77.07 80.96
EBIT 1 10.98 37.67 34.04 14.15 35.25 39.15
Operating Margin 2.62% 7.45% 6.24% 2.66% 6.35% 6.71%
Earnings before Tax (EBT) 1 9.859 38.73 40.81 15.43 41 40.53
Net income 1 -9.556 21.19 22.64 10.86 26.04 31.06
Net margin -2.28% 4.19% 4.15% 2.04% 4.69% 5.32%
EPS 2 -0.0600 0.1100 0.1200 0.0550 0.1340 0.1600
Free Cash Flow 1 63.72 -40.68 - 39.81 51.21 40.28
FCF margin 15.19% -8.04% - 7.49% 9.22% 6.9%
FCF Conversion (EBITDA) 60.55% - - 65.73% 66.44% 49.76%
FCF Conversion (Net income) - - - 366.72% 196.68% 129.71%
Dividend per Share 2 - - - - - -
Announcement Date 08/03/22 28/02/23 28/02/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 102.7 128.7 110.1 122.2 128.6 144.9 120.2 138.1 142.4 144.9 117.4 134.6 133.4 144.9 122.4
EBITDA 1 22.19 31.9 24.98 21.48 21.02 19.76 16.08 18.9 24.42 26.6 8.571 11.14 16.66 23.59 11.35
EBIT 1 10.55 16.43 13.74 9.451 11.21 3.26 3.297 6.566 9.954 14.23 -2.435 -0.2873 4.857 12 1.3
Operating Margin 10.27% 12.77% 12.48% 7.73% 8.72% 2.25% 2.74% 4.75% 6.99% 9.82% -2.07% -0.21% 3.64% 8.28% 1.06%
Earnings before Tax (EBT) 1 9.618 16.31 13.75 9.521 11.82 3.638 4.368 8.083 11.85 16.51 -2.454 -0.5355 5.368 13.25 3.2
Net income 1 6.954 12.6 8.899 4.852 4.044 3.391 1.909 4.582 6.146 10 -1.236 -0.0154 3.396 8.712 0.9323
Net margin 6.77% 9.79% 8.08% 3.97% 3.14% 2.34% 1.59% 3.32% 4.32% 6.9% -1.05% -0.01% 2.55% 6.01% 0.76%
EPS 2 0.0300 0.0600 0.0500 0.0300 0.0200 0.0200 0.0100 0.0200 0.0300 0.0500 -0.008000 -0.002500 0.0180 0.0480 -
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 10/11/21 08/03/22 12/05/22 04/08/22 10/11/22 28/02/23 04/05/23 03/08/23 02/11/23 28/02/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - -
Net Cash position 1 195 160 - 256 317 370
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 63.7 -40.7 - 39.8 51.2 40.3
ROE (net income / shareholders' equity) -5.57% 7.66% - 2.82% 5.19% 6.21%
ROA (Net income/ Total Assets) - 6% - 3% 4.5% 5.4%
Assets 1 - 353.4 - 361.8 578.6 575.1
Book Value Per Share 2 1.540 1.640 - 2.520 2.830 3.170
Cash Flow per Share 2 0.4200 -0.1900 - 0.2900 0.3500 -
Capex 1 2.71 5.35 - 18.6 11.2 18.6
Capex / Sales 0.65% 1.06% - 3.51% 2.02% 3.18%
Announcement Date 08/03/22 28/02/23 28/02/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for FIGS, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
11
Last Close Price
4.92 USD
Average target price
6.25 USD
Spread / Average Target
+27.03%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Supplies

1st Jan change Capi.
FIGS, INC. Stock FIGS, Inc.
-29.21% 837M
COLOPLAST A/S Stock Coloplast A/S
+11.84% 27.79B
SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED Stock Shandong Weigao Group Medical Polymer Company Limited
-32.98% 2.98B
WINNER MEDICAL CO., LTD. Stock Winner Medical Co., Ltd.
-15.97% 2.52B
INTCO MEDICAL TECHNOLOGY CO., LTD. Stock Intco Medical Technology Co., Ltd.
+11.90% 2.34B
HARTALEGA HOLDINGS Stock Hartalega Holdings
-1.11% 1.91B
HARBIN FUERJIA TECHNOLOGY CO., LTD. Stock Harbin Fuerjia Technology Co., Ltd.
-13.37% 1.83B
TOP GLOVE CORPORATION BHD. Stock Top Glove Corporation Bhd.
-7.78% 1.39B
NAKANISHI INC. Stock Nakanishi Inc.
-0.38% 1.27B
KANGJI MEDICAL HOLDINGS LIMITED Stock Kangji Medical Holdings Limited
+4.01% 1.13B
Medical Supplies
  1. Stock Market
  2. Equities
  3. FIGS Stock
  4. Financials FIGS, Inc.